Ahmedz Widiasta

Dr. Ahmedz Widiasta

Universitas Padjadjaran
+1

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2020 in Non-coding RNA Research
Verified
Journal Article
Open access
AWAhmedz Widiasta
Ahmedz Widiasta
YSYunia Sribudiani
Yunia Sribudiani
HNHusna Nugrahapraja
Husna Nugrahapraja
DHDany Hilmanto
Dany Hilmanto
NSNanan Sekarwana
Nanan Sekarwana
DRDedi Rachmadi
Dedi Rachmadi
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is responsible for coronavirus disease (COVID-19), potentially have severe kidney adverse effects. This organ expressed angiotensin-converting enzyme 2 (ACE2), the transmembrane protein which facilitate the entering of the virus into the cell. Therefore, early detection of the kidney manifestations of COVID-19 is crucial. Previous studies showed ACE2 role in various indications of this disease, especially in kidney effects. The MicroRNAs (miRNAs) in this organ affected ACE2 expression. Therefore, this review aims at summarizing the literature of a novel miRNA-based therapy and its potential applications in COVID-19-associated nephropathy. Furthermore, previous studies were analyzed for the kidney manifestations of COVID-19 and the miRNAs role that were published on the online databases, namely MEDLINE (PubMed) and Scopus. Several miRNAs, particularly miR-18 (which was upregulated in nephropathy), played a crucial role in ACE2 expression. Therefore, the antimiR-18 roles were summarized in various primate models that aided in developing the therapy for ACE2 related diseases.

1 February 2022 in International Journal of Nephrology and Renovascular Disease
Verified
Journal Article
Open access
PDF file
DHDany Hilmanto
Dany Hilmanto
FMFitriana Mawardi
Fitriana Mawardi
ALAyuningtyas S Lestari
Ayuningtyas S Lestari
AWAhmedz Widiasta
Ahmedz Widiasta
Introduction: Nephrotic syndrome (NS) is one of the most common childhood kidney diseases. During the active phase, the disease pathogenesis affects various biological functions linked to loss of proteins negatively, which can result in systemic complications. Complications of childhood NS are divided into two categories: disease-associated complications and drug-associated complications. However, complications in pediatric patients with NS, especially disease-associated complications are still limited. Although reported in the literature, information is not comprehensive and needs to be updated. This study aimed to systematically assess systemic complications in children with NS, especially disease-associated complications, to better understand how they impact outcomes. Methods: We conducted a systematic search of several databases: BioMed Central Pediatrics, PubMed, Google Scholar, the National Library of Medicine, Cochrane Library, CINAHL/EBSCO, British Medical Journal, Science Direct, Scopus, and Elsevier’s ClinicalKey. We followed the PRISMA guidelines to plan, conduct, and report this review. We used the Joanna Briggs Institute’s critical appraisal tools for assuring the quality of the journal articles that were chosen. Results: Eleven articles concerning complications in childhood NS were analyzed. Systemic disease-associated complications in covered were cardiovascular complications, infections, thyroid-hormone complication, kidney complications, and oral health complications. Conclusion: NS is marked by heavy proteinuria, hypoalbuminemia, edema, and hyperlipidemia, which can result in systemic disease-associated complications. Cardiovascular complications, infections, thyroid-hormone complications, kidney complications, and oral health complications are the main systemic complications in childhood NS. It is essential that health-care providers prevent these complications for proper maintenance of patients’ health.

25 August 2021 in BioMedicine
Verified
Journal Article
Open access
PDF file
AWAhmedz Widiasta
Ahmedz Widiasta
KWKurnia Wahyudi
Kurnia Wahyudi
YSYunia Sribudiani
Yunia Sribudiani
DRDedi Rachmadi
Dedi Rachmadi
Background:Steroid-resistant nephrotic syndrome (SRNS) is a burden in the country due to the progressive severity of chronic kidney disease (CKD). Calcineurin inhibitors (CNIs) or monoclonal antibodies are currently recommended for the treatment of this disease. In developing countries, steroid and cyclophosphamide (CPA) are available drugs used during the treatment. This study aims to provide a non-invasive modality that can be used to predict the response of SRNS children to CPA therapy. Subsequently, the proteinuria duration was shortened to reduce the risk of glomerular damage. Method:A prospective-cohort-study was conducted at Hasan Sadikin General Hospital Bandung, Indonesia. A total of 88 SRNS children, aged 1 to 18 were accessed for serum TGF-ß level before receiving CPA therapy for six months, and clinical signs were observed. Furthermore, after six months of CPA treatment, the subjects were divided into CPA responder and non-responder based on the present of proteinuria, then the data were analyzed using multiple logistic regression to adjust age and gender. Results:There was a statistically significant relationship between TGF-β and the risk of non-response to CPA therapy, after accounting for age, gender, baseline GFR, baseline ureum, and baseline urinary protein, the adjusted-OR was 1.051 (95% CI 1.007, 1.097, p = 0.022). Conclusion:The high level of serum TGF-β obtained prior to CPA administration are reliable data for estimating adverse results on CPA therapy. Based on these results, a high baseline TGF-β level correlates with the poor response of CPA therapy. Keywords: Albumin-creatinin ratio, correlation, cyclophosphamide, steroid-resistant nephrotic syndrome, TGF-ß

28 October 2022 in International Journal of Nephrology and Renovascular Disease
Verified
Journal Article
Open access
PDF file
EWElrika A Wijaya
Elrika A Wijaya
PSPurboyo Solek
Purboyo Solek
DHDzulfikar Dl Hakim
Dzulfikar Dl Hakim
RRRini Rossanti
Rini Rossanti
AWAhmedz Widiasta
Ahmedz Widiasta
DHDany Hilmanto
Dany Hilmanto
Purpose: In children, chronic kidney disease (CKD) has been known to affect neurocognitive function which can impair the quality of life. This study aims to determine the factors and treatment modalities which might affect neurocognitive function in pediatric population with CKD. Patients and Methods: A systematic review was done using 3 electronic databases: PubMed, ScienceDirect, SpringerLink, and carried out based on PRISMA guidelines. Our review included articles published in the last 10 years (2011– 2021) in English, on children aged 0– 18 years with CKD. Factors affecting the children’s neurocognitive function were assessed. Results: Eight articles were included in this study. Three articles reported that parent’s education, especially maternal education affect the neurocognitive function of children with CKD. In relation with modalities, in general, children with CKD who had kidney transplant had a better neurocognitive outcome. A longer duration of hemodialysis (HD) was associated with poorer neurocognitive outcomes. Other factors that can affect the neurocognitive function included depression, a history of abnormal births, seizures, and hypertension. Conclusion: In children, CKD might cause neurocognitive function disorders through various complex and interconnected mechanisms. Further studies are needed to determine the mechanism and prevention of neurocognitive disorders, as well as the best choice of therapeutic modality to improve both kidney function and neurocognitive function in children with CKD.

25 January 2025 in Nephro-Urology Monthly
Verified
Journal Article
Open access
PDF file
AWAhmedz Widiasta
Ahmedz Widiasta
ALAthaya Nail Labiba
Athaya Nail Labiba
RTRodman Tarigan
Rodman Tarigan
Background: Children with end-stage kidney disease (ESKD) require therapies such as hemodialysis (HD) and peritoneal dialysis (PD). These treatments can impact a child’s quality of life (QoL); however, research comparing the QoL between children undergoing HD and those undergoing chronic PD in developing countries is limited. Objectives: This study compared the QoL of children with ESKD undergoing PD versus HD. Methods: This study employed an analytic observational method with a cross-sectional design conducted from December 2023 to March 2024. Consecutive sampling was used for participant recruitment and data collection. The Pediatric QoL Inventory (PedsQL™) version 4.0 Questionnaire was utilized, and data were analyzed using the Mann-Whitney non-parametric test, with statistical significance set at P < 0.05. Results: The sample consisted of patients undergoing HD (n = 12, 48%) and PD (n = 13, 52%). Based on child and parent reports, the mean QoL score was significantly higher for PD patients compared to HD patients, although no significant differences were observed in certain aspects. The highest score was recorded in children’s reports regarding social aspects (91.53 ± 22.2). Conclusions: The QoL of pediatric patients on PD was better than that of patients on HD.

19 July 2022 in IDCases
Verified
Journal Article
Open access
FSFiha Seratin
Fiha Seratin
AWAhmedz Widiasta
Ahmedz Widiasta
RARiyadi Adrizain
Riyadi Adrizain
DHDany Hilmanto
Dany Hilmanto
Nephrotic syndrome and encephalopathy are uncommon complications that occurred in typhoid fever. The diagnosis is based on proteinuria finding with nephrotic range value, edema, and hypoalbuminemia. In this study, a 10-year-old boy was diagnosed with encephalopathy typhoid and nephrotic syndrome. The physical examination and urinalysis were conducted with methylprednisolone 60 mg/body surface area and captopril to reduce proteinuria.